The Iliac/SFA/Popliteal Center

Filter Your Results




Enrollment Begins in FORTEZ Study of VentureMed's Flex Catheter Plus DCB in SFA

November 14, 2018 -- VentureMed Group, Inc. announced that the first patient with peripheral artery disease (PAD) in the superficial femoral and popliteal arteries has been su…

Data Presented From European Study of Eximo Medical’s B-Laser Atherectomy Catheter

November 8, 2018 -- John R. Laird Jr, MD, presented the European study data on Eximo Medical’s B-Laser atherectomy catheter at VIVA 2018, the Vascular Interventional Adv…

Data From the TOBA II Trial Presented for Intact's Tack Endovascular System

November 6, 2018 -- Intact Vascular, Inc. announced that the company's Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial of the Tack endovascular system achie…

Pooled Analysis Explores Impact of Patient and Lesion Risk Factors on Freedom From TLR With Cook Medical's Zilver PTX DES

November 6, 2018 -- Cook Medical announced that the results from an aggregated data analysis highlighting the company’s Zilver PTX drug-eluting stent (DES) to treat dise…

Five-Year and Pooled Analysis Data Presented for Medtronic's In.Pact Admiral DCB

November 7, 2018 -- Medtronic announced that data reinforcing the durability, safety, and effectiveness of its In.Pact Admiral drug-coated balloon (DCB) in patients with perip…

IMPERIAL Substudy Supports FDA Approval of Boston Scientific's Eluvia DES for Long Lesions in SFA

November 6, 2018 -- Boston Scientific Corporation announced clinical outcomes from the IMPERIAL Long Lesion Substudy demonstrating that the company's Eluvia drug-eluting v…

Interim Data From the MIMICS-3D Registry Presented for Veryan’s BioMimics 3D Stent

November 6, 2018 -- Veryan Medical Ltd. announced interim data from the MIMICS-3D registry of the company’s BioMimics three-dimensional (3D) helical stent that were pres…

Study Explores Impact of Patient Sex on Outcomes in Stellarex Drug-Coated Balloon PAD Treatment

November 6, 2018 -- Data from a subgroup analysis of the Stellarex drug-coated balloon (DCB, Philips) cohort from the ILLUMENATE trial demonstrated that DCB treatment of femor…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.